Top Markets
#1 MowCat MowCat +775.59%
#2 龙虾 (Lobster) 龙虾 (Lobster) +81.18%
#3 Akedo Akedo +43.02%
#4 Magma Finance Magma Finance +42.54%
#5 SIXSEVEN SIXSEVEN +28.89%
#6 MarsCoin MarsCoin +27.75%
#7 DeXe DeXe +27.23%
#8 Cortex Cortex +25.74%
#9 Staked ZIG Staked ZIG +16.36%
#10 Zignaly Zignaly +16.25%
Coin of the day
MowCat MowCat
설정
언어
한국어
통화
USD
테마
Seaport Therapeutics, Inc. Common Stock Seaport Therapeutics, Inc. Common Stock

Seaport Therapeutics, Inc. Common Stock

SPTX
주식 순위 #8294
Seaport Therapeutics, Inc. is a developing biopharmaceutical enterprise... Seaport Therapeutics, Inc. is a developing biopharmaceutical enterprise currently undergoing clinical trials, focused on creating groundbreaking treatments for neuropsychiatric conditions. The company is primarily engaged in tackling disorders like depression and anxiety, utilizing its unique Glyph technology. This exclusive platform is engineered to allow for oral administration of drugs, circumventing initial metabolic processing in the liver, and thereby reducing the risk of liver enzyme elevations, hepatotoxicity, and other potential adverse reactions. Every therapeutic agent in their pipeline incorporates this advanced platform, with all research and development efforts exclusively dedicated to neuropsychiatric applications. Founded in 2024 and situated in Boston, Massachusetts, the company connects with medical professionals and influential experts across the healthcare and neuropsychiatric sectors.
주가
$24.37
시가총액
$1.30B
변동 (1일)
-7.16%
변동 (1년)
-
국가
US
거래 Seaport Therapeutics, Inc. Common Stock (SPTX)

카테고리

Healthcare
Seaport Therapeutics, Inc. Common Stock (SPTX)의 매출
Aug 2026 기준 매출 TTM: 0
Seaport Therapeutics, Inc. Common Stock의 최신 재무 보고서에 따르면 회사의 현재 수익 (TTM)은 0입니다. 2026년에 회사는 0의 수익을 올렸으며 이는 2026년의 0 대비 동일입니다. 수익은 상품이나 서비스를 판매하여 얻은 총 수입을 의미합니다. 수익과는 달리 비용이 차감되지 않습니다.
Seaport Therapeutics, Inc. Common Stock의 수익 기록 (2026 ~ 2026)
매년 말 매출
연도 매출 변화
제공된 날짜에 대한 데이터가 충분하지 않습니다.
유사 기업 또는 경쟁사의 매출
회사 매출 매출 차이 국가
Vertex Pharmaceuticals Incorporated Vertex Pharmaceuticals Incorporated
Vertex Pharmaceuticals Incorporated
VRTX.US
 $12.62B -
US
Argenx SE Argenx SE
Argenx SE
ARGX.US
 $6.02B -
NL
CSL Limited CSL Limited
CSL Limited
CSL.AX
 $15.74B -
AU
Moderna, Inc. Moderna, Inc.
Moderna, Inc.
MRNA.US
 $2.23B -
US
Lonza Group AG Lonza Group AG
Lonza Group AG
LONN.SW
 - -
CH